The FDA review of Pfizer's Covid-19 vaccine in children under 5 years old was delayed after data suggested it was less effective against Omicron than Delta, people familiar with the decision said on.wsj.com
@WSJ3 years ago
Breaking: The FDA has delayed a decision on clearing Moderna's Covid-19 vaccine for 12-to-17-year-olds while it looks into the risk of the rare heart condition myocarditis, people familiar with the matter say on.wsj.com